ArticleJournal of nanobiotechnology2026
Engineered pagoda-like dissolvable microneedle patches for synergistic photothermal antibacterial and wound regenerative therapy.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveDiabetic chronic wounds heal slowly due to persistent inflammation, impaired macrophage polarization, and compromised angiogenesis, while conventional therapies fail to effectively modulate the wound microenvironment. This study aimed to develop pagoda-like microneedle (MN) patches incorporating isoliquiritigenin (ISL)-loaded hollow mesoporous copper sulfide nanoparticles (HMCuS@ISL MNs) with near-infrared (NIR) photothermal functionality to achieve local immunometabolic regulation and promote angiogenesis, antibacterial activity, and wound repair.
methodsHMCuS@ISL nanoparticles were integrated into a collagen/hyaluronic acid matrix to form pagoda-like MN patches. Nanoparticles were characterized by TEM, DLS, and UV-vis-NIR spectroscopy, and their photothermal performance under 808 nm irradiation was evaluated. MN mechanical strength, dissolution, cytocompatibility, antibacterial activity, and in vitro angiogenesis were systematically assessed. ISL-mediated macrophage polarization was analyzed via RNA sequencing, qPCR, flow cytometry, and metabolic flux assays. In vivo efficacy and biosafety were evaluated in streptozotocin-induced diabetic mouse wound models.
resultsHMCuS@ISL nanoparticles displayed uniform hollow-mesoporous morphology with strong NIR absorption and efficient photothermal conversion. MN patches exhibited excellent mechanical strength, rapid dissolution, and good biocompatibility. ISL promoted M2 macrophage polarization by suppressing glycolysis and enhancing fatty acid oxidation. HMCuS@ISL MNs, especially under NIR irradiation, significantly enhanced fibroblast migration, angiogenesis, antibacterial activity, and accelerated wound closure. Histological and immunostaining analyses confirmed improved re-epithelialization, collagen deposition, vascularization, and immune microenvironment balance without systemic toxicity.
conclusionHMCuS@ISL MN patches integrating metabolic immune modulation with photothermal therapy provide an effective, safe, and minimally invasive strategy for diabetic wound healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.